Monopar Therapeutics Inc. · NASDAQ:MNPR

Robinson Chandler exercised options for 6,732 Monopar Therapeutics Inc. shares (Form 4)

Traded Mar 31, 2026 · Filed Apr 2, 2026

On Mar 31, 2026, Robinson Chandler (Director, Chief Executive Officer) exercised options for 6,732 Monopar Therapeutics Inc. shares, leaving 90,478 shares. Filed Apr 2, 2026 (Form 4).

Options exercised
6,732 shares
Holding after
90,478 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 31, 2026Common StockOption exercise6,73292,450Direct
Mar 31, 2026Common StockShares withheld for tax1,972US$54.7990,478Direct

Source

View original at SEC

Related